References

Citations

1. Chosidow O (2006). Scabies. New England Journal of Medicine, 354(16): 1718–1727.

2. Mathieu ME, Wilson BB (2005). Scabies. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases, 6th ed., chap. 292, pp. 3304–3307. Philadelphia: Elsevier Churchill Livingstone.

3. U.S. Food and Drug Administration (2003). FDA issues health advisory regarding labeling changes for lindane products. FDA Talk Paper T03-19. Available online: http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01205.html.

4. Centers for Disease Control and Prevention (2006). Sexually transmitted diseases treatment guidelines, 2006. MMWR, 55(RR-11): 79–80.

5. Stone SP (2003). Scabies and pediculosis. In IM Freedberg et al., eds., Fitzpatrick's Dermatology in General Medicine, 6th ed., vol. 2, chap. 238, pp. 2283–2289. New York: McGraw-Hill.

6. U.S. Food and Drug Administration (2003). FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice. Available online: http://www.fda.gov/cder/drug/infopage/lindane/lindanePHA.htm.